ALBO

Albireo Pharma (ALBO)

Albireo Pharma Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ALBO

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
05/17/2024	3:00PM	iHub Newswire	FeaturedMusic Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements
02/14/2024	8:33AM	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ALBO	Albireo Pharma Inc
03/09/2023	6:14AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ALBO	Albireo Pharma Inc
03/09/2023	6:11AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ALBO	Albireo Pharma Inc
03/09/2023	6:08AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ALBO	Albireo Pharma Inc
03/09/2023	6:05AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ALBO	Albireo Pharma Inc
03/03/2023	6:06AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALBO	Albireo Pharma Inc
03/02/2023	5:03PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALBO	Albireo Pharma Inc
03/02/2023	4:56PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALBO	Albireo Pharma Inc
03/02/2023	4:53PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALBO	Albireo Pharma Inc
03/02/2023	4:53PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ALBO	Albireo Pharma Inc
03/02/2023	4:50PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ALBO	Albireo Pharma Inc
03/02/2023	4:49PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ALBO	Albireo Pharma Inc
03/02/2023	4:49PM	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:ALBO	Albireo Pharma Inc
03/02/2023	4:49PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ALBO	Albireo Pharma Inc
03/02/2023	4:49PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALBO	Albireo Pharma Inc
03/02/2023	4:48PM	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:ALBO	Albireo Pharma Inc
03/02/2023	4:48PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ALBO	Albireo Pharma Inc
03/02/2023	4:47PM	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:ALBO	Albireo Pharma Inc
03/02/2023	4:47PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ALBO	Albireo Pharma Inc
03/02/2023	4:45PM	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:ALBO	Albireo Pharma Inc
03/02/2023	4:44PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALBO	Albireo Pharma Inc
03/02/2023	4:42PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALBO	Albireo Pharma Inc
03/02/2023	4:41PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALBO	Albireo Pharma Inc
03/02/2023	4:40PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALBO	Albireo Pharma Inc
03/02/2023	4:32PM	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:ALBO	Albireo Pharma Inc
03/02/2023	4:29PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALBO	Albireo Pharma Inc
03/02/2023	11:29AM	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:ALBO	Albireo Pharma Inc
03/02/2023	11:24AM	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:ALBO	Albireo Pharma Inc
02/27/2023	4:06PM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ALBO	Albireo Pharma Inc